Free Trial

Lexeo Therapeutics (LXEO) Earnings Date, Estimates & Call Transcripts

$15.19
+0.19 (+1.27%)
(As of 05/29/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 4Estimated
Actual EPS
(May. 9)
-$0.77 Missed By -$0.01
Consensus EPS
(May. 9)
-$0.76
Skip Charts & View Estimated and Actual Earnings Data

LXEO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LXEO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lexeo Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.10)($1.10)($1.10)
Q2 20241($1.09)($1.09)($1.09)
Q3 20241($1.09)($1.09)($1.09)
Q4 20241($1.08)($1.08)($1.08)
FY 20244($4.36)($4.36)($4.36)

LXEO Earnings Date and Information

Lexeo Therapeutics last issued its quarterly earnings data on May 9th, 2024. The reported ($0.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.76) by $0.01. Lexeo Therapeutics has generated ($22.29) earnings per share over the last year (($22.29) diluted earnings per share). Earnings for Lexeo Therapeutics are expected to grow in the coming year, from ($2.67) to ($2.46) per share. Lexeo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.

Lexeo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/4/2024
(Estimated)
------- 
5/9/2024Q1 2024($0.76)($0.77)($0.01)($0.77)--
3/11/2024Q4 2023($0.71)($0.86)($0.15)($0.86)--
12/11/2023Q3 2023($0.96)($12.36)($11.40)($12.36)--
10/30/2023Q2 2023-($8.30)($8.30)($8.30)--

Lexeo Therapeutics Earnings - Frequently Asked Questions

When is Lexeo Therapeutics's earnings date?

Lexeo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on LXEO's earnings history.

Did Lexeo Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Lexeo Therapeutics (NASDAQ:LXEO) missed the analysts' consensus estimate of ($0.76) by $0.01 with a reported earnings per share (EPS) of ($0.77). Learn more on analysts' earnings estimate vs. LXEO's actual earnings.

How much revenue does Lexeo Therapeutics generate each year?

Lexeo Therapeutics (NASDAQ:LXEO) has a recorded annual revenue of $650,000.00.

How much profit does Lexeo Therapeutics generate each year?

Lexeo Therapeutics (NASDAQ:LXEO) has a recorded net income of -$66.39 million. LXEO has generated -$22.29 earnings per share over the last four quarters.

What is Lexeo Therapeutics's EPS forecast for next year?

Lexeo Therapeutics's earnings are expected to grow from ($2.67) per share to ($2.46) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:LXEO) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners